首页 > 最新文献

International Journal of Tuberculosis and Lung Disease最新文献

英文 中文
The impact of the COVID-19 pandemic on TB in a low TB burden setting. 在结核病负担较轻的环境中,COVID-19 大流行对结核病的影响。
IF 3.1 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2024-10-01 DOI: 10.5588/ijtld.24.0040
A Maldari, M Brigham, T I Emeto, O Adegboye, S Barry
{"title":"The impact of the COVID-19 pandemic on TB in a low TB burden setting.","authors":"A Maldari, M Brigham, T I Emeto, O Adegboye, S Barry","doi":"10.5588/ijtld.24.0040","DOIUrl":"10.5588/ijtld.24.0040","url":null,"abstract":"","PeriodicalId":14411,"journal":{"name":"International Journal of Tuberculosis and Lung Disease","volume":"28 10","pages":"510-512"},"PeriodicalIF":3.1,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142346693","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Making social protection a reality for people with TB: a perspective on new global guidance. 为肺结核患者实现社会保护:对新全球指南的看法。
IF 3.1 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2024-10-01 DOI: 10.5588/ijtld.24.0361
L Vanleeuw, M Sanchez, R Forse, W Zembe-Mkabile, S Atkins, T Wingfield

TB disproportionately affects poorer, vulnerable people and communities, and has severe social and economic impacts on those affected. However, many countries do not yet include social protection in their programmatic response to TB. Here, we provide a critical perspective on the guidance developed by the WHO and the International Labour Organization (ILO) to help countries implement social protection programmes. The guidance emphasises the need for a multisectoral response to TB, and includes practical information on how to design appropriate social protection programmes that respond to the needs of people affected by TB.

结核病不成比例地影响着较贫穷的弱势人群和社区,并对受影响者造成严重的社会和经济影响。然而,许多国家尚未将社会保护纳入其应对结核病的计划中。在此,我们对世界卫生组织和国际劳工组织(ILO)为帮助各国实施社会保护计划而制定的指南提出了批判性的看法。该指南强调了对结核病采取多部门应对措施的必要性,并包含了有关如何设计适当的社会保护计划以满足结核病患者需求的实用信息。
{"title":"Making social protection a reality for people with TB: a perspective on new global guidance.","authors":"L Vanleeuw, M Sanchez, R Forse, W Zembe-Mkabile, S Atkins, T Wingfield","doi":"10.5588/ijtld.24.0361","DOIUrl":"10.5588/ijtld.24.0361","url":null,"abstract":"<p><p>TB disproportionately affects poorer, vulnerable people and communities, and has severe social and economic impacts on those affected. However, many countries do not yet include social protection in their programmatic response to TB. Here, we provide a critical perspective on the guidance developed by the WHO and the International Labour Organization (ILO) to help countries implement social protection programmes. The guidance emphasises the need for a multisectoral response to TB, and includes practical information on how to design appropriate social protection programmes that respond to the needs of people affected by TB.</p>","PeriodicalId":14411,"journal":{"name":"International Journal of Tuberculosis and Lung Disease","volume":"28 10","pages":"473-475"},"PeriodicalIF":3.1,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142346771","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nationwide evaluation of treatment outcomes and survival of patients with non-tuberculous mycobacterial pulmonary disease. 对非结核分枝杆菌肺病患者的治疗效果和存活率进行全国性评估。
IF 3.1 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2024-10-01 DOI: 10.5588/ijtld.24.0068
M J Makek, G Glodic, I Sabol, L Zmak, M Samarzija, A Sola, A Marusic, I Marekovic, L K Bulat, L Corak, M Obrovac, J van Ingen

BACKGROUNDTreatment outcomes and long-term survival of non-tuberculous mycobacterial pulmonary disease (NTM-PD) in a real-world setting are difficult to assess, especially for species other than Mycobacterium avium complex (MAC).METHODSThis was a retrospective cohort study on all Croatian residents with respiratory NTM isolates from 2006 to 2015, with follow-up to 2020.RESULTSTherapy was started in 98/137 (71.5%) of patients, significantly more often in patients with fibrocavitary disease and/or sputum smear positivity. Unsuccessful treatment outcomes were recorded in 39/98 (39.8%) patients (14 deaths and 25 treatment failures). One-year and 5-year all-cause mortality were respectively 18.2% and 37.6%. Guideline-based treatment (GBT) was started in 50/98 (51%) of treated patients and followed for the recommended duration in 35.7% (35/98). This resulted in a higher chance of cure (OR 3.79, 95% CI 1.29 to 11.1; P = 0.012) than inadequately treated/untreated patients. For Mycobacterium xenopi disease, high cure rates (>80%) were achieved both with GBT and non-GBT treatment regimens.CONCLUSIONGuideline-based therapy resulted in a four-time higher chance of being cured. The impact of GBT on treatment outcomes was clear for MAC disease, but no apparent effect was observed for patients with M. xenopi disease..

背景在现实世界中,非结核分枝杆菌肺病(NTM-PD)的治疗效果和长期存活率很难评估,尤其是对非结核分枝杆菌复合体(MAC)的治疗效果和长期存活率。结果98/137(71.5%)名患者开始接受治疗,其中纤维空洞症和/或痰涂片阳性患者的治疗率明显更高。39/98(39.8%)例患者治疗失败(14 例死亡和 25 例治疗失败)。一年和五年全因死亡率分别为 18.2% 和 37.6%。50/98(51%)名接受治疗的患者开始接受基于指南的治疗(GBT),35.7%(35/98)的患者按照建议的疗程接受治疗。与治疗不当/未接受治疗的患者相比,这种治疗方法的治愈率更高(OR 3.79,95% CI 1.29 至 11.1;P = 0.012)。对于异种分枝杆菌疾病,采用 GBT 和非 GBT 治疗方案的治愈率都很高(>80%)。GBT对MAC疾病治疗结果的影响是显而易见的,但对M. xenopi病患者没有明显的影响。
{"title":"Nationwide evaluation of treatment outcomes and survival of patients with non-tuberculous mycobacterial pulmonary disease.","authors":"M J Makek, G Glodic, I Sabol, L Zmak, M Samarzija, A Sola, A Marusic, I Marekovic, L K Bulat, L Corak, M Obrovac, J van Ingen","doi":"10.5588/ijtld.24.0068","DOIUrl":"10.5588/ijtld.24.0068","url":null,"abstract":"<p><p><sec><title>BACKGROUND</title>Treatment outcomes and long-term survival of non-tuberculous mycobacterial pulmonary disease (NTM-PD) in a real-world setting are difficult to assess, especially for species other than <i>Mycobacterium avium</i> complex (MAC).</sec><sec><title>METHODS</title>This was a retrospective cohort study on all Croatian residents with respiratory NTM isolates from 2006 to 2015, with follow-up to 2020.</sec><sec><title>RESULTS</title>Therapy was started in 98/137 (71.5%) of patients, significantly more often in patients with fibrocavitary disease and/or sputum smear positivity. Unsuccessful treatment outcomes were recorded in 39/98 (39.8%) patients (14 deaths and 25 treatment failures). One-year and 5-year all-cause mortality were respectively 18.2% and 37.6%. Guideline-based treatment (GBT) was started in 50/98 (51%) of treated patients and followed for the recommended duration in 35.7% (35/98). This resulted in a higher chance of cure (OR 3.79, 95% CI 1.29 to 11.1; <i>P</i> = 0.012) than inadequately treated/untreated patients. For <i>Mycobacterium xenopi</i> disease, high cure rates (>80%) were achieved both with GBT and non-GBT treatment regimens.</sec><sec><title>CONCLUSION</title>Guideline-based therapy resulted in a four-time higher chance of being cured. The impact of GBT on treatment outcomes was clear for MAC disease, but no apparent effect was observed for patients with <i>M. xenopi</i> disease.</sec>.</p>","PeriodicalId":14411,"journal":{"name":"International Journal of Tuberculosis and Lung Disease","volume":"28 10","pages":"482-487"},"PeriodicalIF":3.1,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142346690","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cavitary lung lesions and quality of life after TB. 肺空洞病变与肺结核后的生活质量
IF 3.1 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2024-10-01 DOI: 10.5588/ijtld.23.0590
N Smirnova, C S Bryan, A D Salindri, T Avaliani, L Goginashvili, M Gujabidze, R R Kempker, H Kornfeld, S C Auld, S Vashakidze, Z Avaliani, D Kavalieratos, M Kipiani, M J Magee
{"title":"Cavitary lung lesions and quality of life after TB.","authors":"N Smirnova, C S Bryan, A D Salindri, T Avaliani, L Goginashvili, M Gujabidze, R R Kempker, H Kornfeld, S C Auld, S Vashakidze, Z Avaliani, D Kavalieratos, M Kipiani, M J Magee","doi":"10.5588/ijtld.23.0590","DOIUrl":"10.5588/ijtld.23.0590","url":null,"abstract":"","PeriodicalId":14411,"journal":{"name":"International Journal of Tuberculosis and Lung Disease","volume":"28 10","pages":"505-507"},"PeriodicalIF":3.1,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11544420/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142346767","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of testing face-mask filter samples with LAMP shows high rates of detection in pulmonary TB. 用 LAMP 检测面罩过滤器样本的评估显示,肺结核的检出率很高。
IF 3.1 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2024-10-01 DOI: 10.5588/ijtld.24.0190
T Kodama, K Chikamatsu, K Kamada, K Mizuno, Y Morishige, Y Igarashi, A Osugi, A Aono, Y Murase, M Okumura, T Yoshiyama, A Takaki, S Mitarai

BACKGROUNDDetection of Mycobacterium tuberculosis (MTB) in bioaerosols derived from patients with active pulmonary TB is a potential alternative diagnostic method for patients with presumed TB who cannot expectorate sputum.OBJECTIVETo assess the efficacy of a bioaerosol particle collection method to capture MTB and diagnose TB.METHODSA mask-like filter holder (3D mask) with a water-soluble gelatine filter (GF) and one containing a water-insoluble polypropylene filter (PPF) were prepared. Eligible patients wore the 3D mask with GF or PPF within 3 days of starting anti-TB drugs. The GF and PPF filters were collected after 2 and 8 h. DNA was extracted from the filter samples and tested using loop-mediated isothermal amplification (LAMP).RESULTSFilter samples were collected from 57 and 20 patients with and without active pulmonary TB, respectively. The GF and PPF sensitivity was 76.2% and 83.3%, respectively. The specificity of both methods was 100%. Of the 57 patients diagnosed with non-expectorated sputum samples, including suction phlegm, gastric lavage, and bronchial lavage fluid, 55.6% and 50.0% were positive by GF and PPF, respectively.CONCLUSIONWe present a 3D mask filter sampling method for exhaled bioaerosol particles that can be used in clinical practice to diagnose patients with presumed TB..

背景从活动性肺结核患者产生的生物气溶胶中检测结核分枝杆菌(MTB)是一种潜在的替代诊断方法,适用于无法排痰的推测肺结核患者。符合条件的患者在开始服用抗结核药物后 3 天内佩戴装有 GF 或 PPF 的三维口罩。结果分别从 57 名和 20 名活动性肺结核患者和非活动性肺结核患者身上采集了过滤器样本。GF 和 PPF 的灵敏度分别为 76.2% 和 83.3%。两种方法的特异性均为 100%。在 57 名诊断为非排痰(包括吸痰、洗胃和支气管灌洗液)的患者中,GF 和 PPF 的阳性率分别为 55.6% 和 50.0%。
{"title":"Evaluation of testing face-mask filter samples with LAMP shows high rates of detection in pulmonary TB.","authors":"T Kodama, K Chikamatsu, K Kamada, K Mizuno, Y Morishige, Y Igarashi, A Osugi, A Aono, Y Murase, M Okumura, T Yoshiyama, A Takaki, S Mitarai","doi":"10.5588/ijtld.24.0190","DOIUrl":"10.5588/ijtld.24.0190","url":null,"abstract":"<p><p><sec><title>BACKGROUND</title>Detection of <i>Mycobacterium tuberculosis</i> (MTB) in bioaerosols derived from patients with active pulmonary TB is a potential alternative diagnostic method for patients with presumed TB who cannot expectorate sputum.</sec><sec><title>OBJECTIVE</title>To assess the efficacy of a bioaerosol particle collection method to capture MTB and diagnose TB.</sec><sec><title>METHODS</title>A mask-like filter holder (3D mask) with a water-soluble gelatine filter (GF) and one containing a water-insoluble polypropylene filter (PPF) were prepared. Eligible patients wore the 3D mask with GF or PPF within 3 days of starting anti-TB drugs. The GF and PPF filters were collected after 2 and 8 h. DNA was extracted from the filter samples and tested using loop-mediated isothermal amplification (LAMP).</sec><sec><title>RESULTS</title>Filter samples were collected from 57 and 20 patients with and without active pulmonary TB, respectively. The GF and PPF sensitivity was 76.2% and 83.3%, respectively. The specificity of both methods was 100%. Of the 57 patients diagnosed with non-expectorated sputum samples, including suction phlegm, gastric lavage, and bronchial lavage fluid, 55.6% and 50.0% were positive by GF and PPF, respectively.</sec><sec><title>CONCLUSION</title>We present a 3D mask filter sampling method for exhaled bioaerosol particles that can be used in clinical practice to diagnose patients with presumed TB.</sec>.</p>","PeriodicalId":14411,"journal":{"name":"International Journal of Tuberculosis and Lung Disease","volume":"28 10","pages":"476-481"},"PeriodicalIF":3.1,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142346769","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Health status of Italian children living close to cultivations sprayed with pesticides. 生活在喷洒过杀虫剂的农田附近的意大利儿童的健康状况。
IF 3.1 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2024-10-01 DOI: 10.5588/ijtld.24.0104
G Sarno, S Maio, S Baldacci, I Stanisci, A Angino, S Tagliaferro, P Silvi, G Viegi

BACKGROUNDPesticides are used to control pests, but they are toxic and may severely harm children's health. We assessed health outcomes in Italian children living close to cultivations sprayed with pesticides.METHODSIn 2011-2012, 2,367 schoolchildren (6-14 years) living in eight Italian cities participated in the Indoor-School observational study. Parents filled in a standardised questionnaire on children's health and related risk factors. Children were classified as exposed to pesticides if living close to cultivations sprayed with pesticides. The association between the last three months of respiratory, allergic or systemic symptoms and pesticide exposure was assessed by multinomial logistic regression models, accounting for host/environmental risk factors.RESULTSOverall, 14% of children were exposed to pesticides, with significant differences among geographical areas: 21.2% in Northern Italy, 11.6% in Central Italy, and 9.7% in Southern Italy. Pesticide exposure was significantly associated with having: 1) 'often': eye symptoms (OR 3.81, 95% CI 2.06-7.05), skin symptoms (OR 2.60, 95% CI 1.34-5.03), lower airway symptoms (OR 2.38, 95% CI 1.41-4.01), systemic symptoms (OR 1.56, 95% CI 0.96-2.53, borderline); 2) 'daily': upper airways symptoms (OR 2.25, 95% CI 1.25-4.07) and systemic symptoms (OR 2.76, 95% CI 1.43-5.34).CONCLUSIONSSelf-reported pesticide exposure was associated with respiratory, allergic or systemic symptoms in children. Public authorities should be aware of and intervene to mitigate this health risk..

背景杀虫剂用于控制害虫,但它们具有毒性,可能会严重危害儿童健康。我们对居住在喷洒过杀虫剂的农田附近的意大利儿童的健康状况进行了评估。方法 2011-2012年,居住在意大利八个城市的2367名学龄儿童(6-14岁)参加了室内-学校观察研究。家长填写了一份关于儿童健康和相关风险因素的标准化问卷。如果儿童居住的地方靠近喷洒过杀虫剂的农田,则被归类为接触过杀虫剂的儿童。通过多项式逻辑回归模型评估了最近三个月出现的呼吸道、过敏或全身症状与接触杀虫剂之间的关系,并考虑了宿主/环境风险因素:意大利北部为 21.2%,意大利中部为 11.6%,意大利南部为 9.7%。接触杀虫剂与以下情况有明显关系2)"每日":上呼吸道症状(OR 2.25,95% CI 1.25-4.07)和全身症状(OR 2.76,95% CI 1.43-5.34)。公共当局应该意识到并采取干预措施来降低这种健康风险。
{"title":"Health status of Italian children living close to cultivations sprayed with pesticides.","authors":"G Sarno, S Maio, S Baldacci, I Stanisci, A Angino, S Tagliaferro, P Silvi, G Viegi","doi":"10.5588/ijtld.24.0104","DOIUrl":"10.5588/ijtld.24.0104","url":null,"abstract":"<p><p><sec><title>BACKGROUND</title>Pesticides are used to control pests, but they are toxic and may severely harm children's health. We assessed health outcomes in Italian children living close to cultivations sprayed with pesticides.</sec><sec><title>METHODS</title>In 2011-2012, 2,367 schoolchildren (6-14 years) living in eight Italian cities participated in the Indoor-School observational study. Parents filled in a standardised questionnaire on children's health and related risk factors. Children were classified as exposed to pesticides if living close to cultivations sprayed with pesticides. The association between the last three months of respiratory, allergic or systemic symptoms and pesticide exposure was assessed by multinomial logistic regression models, accounting for host/environmental risk factors.</sec><sec><title>RESULTS</title>Overall, 14% of children were exposed to pesticides, with significant differences among geographical areas: 21.2% in Northern Italy, 11.6% in Central Italy, and 9.7% in Southern Italy. Pesticide exposure was significantly associated with having: 1) 'often': eye symptoms (OR 3.81, 95% CI 2.06-7.05), skin symptoms (OR 2.60, 95% CI 1.34-5.03), lower airway symptoms (OR 2.38, 95% CI 1.41-4.01), systemic symptoms (OR 1.56, 95% CI 0.96-2.53, borderline); 2) 'daily': upper airways symptoms (OR 2.25, 95% CI 1.25-4.07) and systemic symptoms (OR 2.76, 95% CI 1.43-5.34).</sec><sec><title>CONCLUSIONS</title>Self-reported pesticide exposure was associated with respiratory, allergic or systemic symptoms in children. Public authorities should be aware of and intervene to mitigate this health risk.</sec>.</p>","PeriodicalId":14411,"journal":{"name":"International Journal of Tuberculosis and Lung Disease","volume":"28 10","pages":"500-504"},"PeriodicalIF":3.1,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142346770","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
TB outpatient care in a high-income, low-incidence country. 一个高收入、低发病率国家的结核病门诊护理。
IF 3.1 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2024-10-01 DOI: 10.5588/ijtld.24.0059
N Riccardi, C Monari, R M Antonello, L Saderi, S Occhineri, A Pontarelli, P Zucchi, D Buonsenso, E Falbo, P Faverio, S Aliberti, R Parrella, M Falcone, G Besozzi, A Calcagno, D Goletti, G Gualano, G Sotgiu, M Tadolini, L Codecasa
{"title":"TB outpatient care in a high-income, low-incidence country.","authors":"N Riccardi, C Monari, R M Antonello, L Saderi, S Occhineri, A Pontarelli, P Zucchi, D Buonsenso, E Falbo, P Faverio, S Aliberti, R Parrella, M Falcone, G Besozzi, A Calcagno, D Goletti, G Gualano, G Sotgiu, M Tadolini, L Codecasa","doi":"10.5588/ijtld.24.0059","DOIUrl":"10.5588/ijtld.24.0059","url":null,"abstract":"","PeriodicalId":14411,"journal":{"name":"International Journal of Tuberculosis and Lung Disease","volume":"28 10","pages":"513-515"},"PeriodicalIF":3.1,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142346692","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lung function and health-related quality of life among adult patients following pulmonary TB treatment. 肺结核治疗后成年患者的肺功能和与健康相关的生活质量。
IF 3.1 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2024-09-01 DOI: 10.5588/ijtld.24.0029
J Zawedde, R Abelman, E Musisi, A Nyabigambo, I Sanyu, S Kaswabuli, P Byanyima, E Lewis, A Sessolo, R Lalitha, N Kiwanuka, K Crothers, W Worodria, J L Davis, L Huang

OBJECTIVESPulmonary TB (PTB) increases the risk of chronic lung complications, which are associated with increased morbidity and mortality. We determined the prevalence and predictors of post-TB lung disease and persistent symptoms in a resource-limited setting.METHODSAdults who completed PTB treatment underwent spirometry and completed the St. George's Respiratory Questionnaire (SGRQ), a questionnaire that assesses quality of life on symptom, activity, and impact. We performed multivariate analyses to calculate the X-adjusted prevalence ratio (PRadj) of abnormal spirometry and identify associated risk factors.RESULTSAmong the 162 participants, 89 (54.9%) were male. The median age was 32 years, and 65 (40.1%) had HIV. Overall, 65 participants (40.1%) had abnormal lung function, with spirometric restriction seen in 29.0%, obstruction in 4.9%, and a mixed pattern in 6.2%. Smoking (PRadj 1.88, 95% CI 1.11-3.16; P = 0.02) and female sex (PRadj 1.81, 95% Cl 1.15-2.84; P = 0.01) were independent risk factors for abnormal lung function. The median SGRQ scores were higher in participants with cavitation (P < 0.001) or bilateral consolidation on initial chest X-ray (P = 0.01).CONCLUSIONSLung function abnormalities, particularly spirometric restriction, are common in patients completing PTB treatment. Female sex and smoking status were associated with lung function abnormalities; therefore, additional studies to understand the underlying mechanistic pathways are warranted..

目的肺结核(PTB)会增加慢性肺部并发症的风险,而这些并发症与发病率和死亡率的增加有关。方法对完成 PTB 治疗的成人进行肺活量测定,并填写圣乔治呼吸系统问卷 (SGRQ),这是一份评估症状、活动和影响等生活质量的问卷。我们进行了多变量分析,以计算肺活量异常的 X 调整流行率 (PRadj),并确定相关的风险因素。年龄中位数为 32 岁,65 人(40.1%)感染了艾滋病毒。总体而言,65 名参与者(40.1%)肺功能异常,其中 29.0% 的人肺功能受限,4.9% 的人肺功能受阻,6.2% 的人肺功能呈混合型。吸烟(PRadj 1.88,95% CI 1.11-3.16;P = 0.02)和女性(PRadj 1.81,95% Cl 1.15-2.84;P = 0.01)是肺功能异常的独立危险因素。结论肺功能异常,尤其是肺活量限制,在完成 PTB 治疗的患者中很常见。女性性别和吸烟状况与肺功能异常有关;因此,有必要开展更多研究,以了解潜在的机理途径。
{"title":"Lung function and health-related quality of life among adult patients following pulmonary TB treatment.","authors":"J Zawedde, R Abelman, E Musisi, A Nyabigambo, I Sanyu, S Kaswabuli, P Byanyima, E Lewis, A Sessolo, R Lalitha, N Kiwanuka, K Crothers, W Worodria, J L Davis, L Huang","doi":"10.5588/ijtld.24.0029","DOIUrl":"10.5588/ijtld.24.0029","url":null,"abstract":"<p><p><sec><title>OBJECTIVES</title>Pulmonary TB (PTB) increases the risk of chronic lung complications, which are associated with increased morbidity and mortality. We determined the prevalence and predictors of post-TB lung disease and persistent symptoms in a resource-limited setting.</sec><sec><title>METHODS</title>Adults who completed PTB treatment underwent spirometry and completed the St. George's Respiratory Questionnaire (SGRQ), a questionnaire that assesses quality of life on symptom, activity, and impact. We performed multivariate analyses to calculate the X-adjusted prevalence ratio (PR<sub>adj</sub>) of abnormal spirometry and identify associated risk factors.</sec><sec><title>RESULTS</title>Among the 162 participants, 89 (54.9%) were male. The median age was 32 years, and 65 (40.1%) had HIV. Overall, 65 participants (40.1%) had abnormal lung function, with spirometric restriction seen in 29.0%, obstruction in 4.9%, and a mixed pattern in 6.2%. Smoking (PR<sub>adj</sub> 1.88, 95% CI 1.11-3.16; <i>P</i> = 0.02) and female sex (PR<sub>adj</sub> 1.81, 95% Cl 1.15-2.84; <i>P</i> = 0.01) were independent risk factors for abnormal lung function. The median SGRQ scores were higher in participants with cavitation (<i>P</i> < 0.001) or bilateral consolidation on initial chest X-ray (<i>P =</i> 0.01).</sec><sec><title>CONCLUSIONS</title>Lung function abnormalities, particularly spirometric restriction, are common in patients completing PTB treatment. Female sex and smoking status were associated with lung function abnormalities; therefore, additional studies to understand the underlying mechanistic pathways are warranted.</sec>.</p>","PeriodicalId":14411,"journal":{"name":"International Journal of Tuberculosis and Lung Disease","volume":"28 9","pages":"419-426"},"PeriodicalIF":3.1,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12312260/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142072840","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Respiratory impairment after completion of TB treatment: a neglected but vitally important issue. 肺结核治疗结束后的呼吸系统损伤:一个被忽视但极其重要的问题。
IF 3.4 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2024-09-01 DOI: 10.5588/ijtld.24.0341
L N Nguyen, P T Phan, E Jaramillo, A Dinh, A T Dinh-Xuan
{"title":"Respiratory impairment after completion of TB treatment: a neglected but vitally important issue.","authors":"L N Nguyen, P T Phan, E Jaramillo, A Dinh, A T Dinh-Xuan","doi":"10.5588/ijtld.24.0341","DOIUrl":"10.5588/ijtld.24.0341","url":null,"abstract":"","PeriodicalId":14411,"journal":{"name":"International Journal of Tuberculosis and Lung Disease","volume":"28 9","pages":"410-411"},"PeriodicalIF":3.4,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142072755","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cold temperatures during sample transportation may cause false-negative interferon-γ release assays used to diagnose TB infection. 样本运输过程中的低温可能会导致用于诊断肺结核感染的干扰素-γ 释放检测出现假阴性。
IF 3.4 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2024-09-01 DOI: 10.5588/ijtld.24.0020
K Takeda, H Nagai, M Kawashima, I Kosai, M Shimozono, K Sato, H Motomura, E Nakano, M Watanabe, T Kato, M Shimada, O Narumoto, M Suzukawa, J Suzuki, K Yamane, Y Sasaki, Y Morio, A Tamura, H Matsui
{"title":"Cold temperatures during sample transportation may cause false-negative interferon-γ release assays used to diagnose TB infection.","authors":"K Takeda, H Nagai, M Kawashima, I Kosai, M Shimozono, K Sato, H Motomura, E Nakano, M Watanabe, T Kato, M Shimada, O Narumoto, M Suzukawa, J Suzuki, K Yamane, Y Sasaki, Y Morio, A Tamura, H Matsui","doi":"10.5588/ijtld.24.0020","DOIUrl":"10.5588/ijtld.24.0020","url":null,"abstract":"","PeriodicalId":14411,"journal":{"name":"International Journal of Tuberculosis and Lung Disease","volume":"28 9","pages":"467-469"},"PeriodicalIF":3.4,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142072837","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International Journal of Tuberculosis and Lung Disease
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1